NASDAQ
Poniard Pharmaceuticals, Inc. (PARD) has a revenue compound annual growth rate of -66.49% over 5 years and -25.89% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.